Rational Combination of Immunotherapy for TNBC Treatment Rational Combination of Immunotherapy for TNBC Treatment

Chemotherapeutic and targeted agents may enhance anti-tumor immunity against TNBC by reducing PD-L1 expression.Chinese Clinical Oncology

Source: Medscape Today Headlines - January 23, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news